Position in ACAD
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$42,957,805
+$26,711,656 QoQ
Shares Held
1,697,937
+132.6% QoQ
Ownership
0.985%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#17
of 354 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 97%
Shared 0%
None 3%
Common Shares in ACAD Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026D. E. Shaw & Co., Inc. holds $5,139,216,221 across 217 Biotechnology names. ACAD ranks #30 (0.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | INSM |
INSMED Inc
|
5,877,959 | $626,707,987 | |
| 2 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
1,104,109 | $332,369,932 | |
| 3 | EXEL |
Exelixis, Inc.
|
5,551,747 | $302,070,554 | |
| 4 | BBIO |
BridgeBio Pharma, Inc.
|
3,633,007 | $270,586,360 | |
| 5 | TGTX |
Tg Therapeutics, Inc.
|
3,400,808 | $186,840,390 | |
| 6 | HALO |
Halozyme Therapeutics, Inc.
|
2,006,479 | $157,047,110 | |
| 7 | AXSM |
Axsome Therapeutics, Inc.
|
604,753 | $148,025,391 | |
| 8 | PTCT |
Ptc Therapeutics, Inc.
|
1,548,919 | $126,345,322 |
All Filings in ACAD
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $42,957,805 | 1,697,937 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $16,246,149 | 729,836 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $27,425,426 | 1,026,785 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $33,315,175 | 1,561,161 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $42,374,717 | 1,964,521 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $39,023,865 | 2,349,420 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $59,479,799 | 3,241,406 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $53,906,237 | 3,504,957 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $47,692,546 | 2,934,926 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $48,850,949 | 2,642,020 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $117,556,462 | 3,754,598 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $99,802,717 | 4,788,998 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $126,050,717 | 5,263,078 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $92,228,952 | 4,900,582 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $67,172,831 | 4,219,399 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $77,091,264 | 4,712,180 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $66,035,109 | 4,686,665 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $110,127,443 | 4,546,963 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $105,664,917 | 4,527,203 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $92,526,535 | 5,570,532 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $116,219,934 | 4,765,065 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $60,764,366 | 2,355,208 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $119,900,087 | 2,242,800 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $93,411,161 | 2,264,513 | Shares | Defined | 2020-11-16 | |
| 2020-06-30 | $104,123,641 | 2,148,208 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $54,507,949 | 1,290,129 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||